Associated Papers
Association of SHANK Family with Neuropsychiatric Disorders: An Update on Genetic and Animal Model Discoveries.
Wan L et al.
Cellular and Molecular Neurobiology, 2022
SHANK3 Genotype Mediates Speech and Language Phenotypes in a Nonclinical Population.
Manning C et al.
Autism Research and Treatment, 2021
Application of Human-Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders.
Shen X et al.
Developmental Neurobiology, 2019
Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature.
Kolevzon A et al.
Molecular Autism, 2019
Structural basis for PDZ domain interactions in the post-synaptic density scaffolding protein Shank3.
Ponna SK et al.
Journal of Neurochemistry, 2018
Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations.
De Rubeis S et al.
Molecular Autism, 2018
Investigation of SHANK3 in schizophrenia.
de Sena Cortabitarte A et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2017
The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation.
Grabrucker S et al.
Experimental Neurology, 2014
The emerging role of SHANK genes in neuropsychiatric disorders.
Guilmatre A et al.
Developmental Neurobiology, 2014
Genetic copy number variation and general cognitive ability.
MacLeod AK et al.
Plos One, 2012
A strategy to identify de novo mutations in common disorders such as autism and schizophrenia.
Julie G et al.
Journal of Visualized Experiments : Jove, 2011
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.
Gauthier J et al.
Proceedings of the National Academy of Sciences of the United States of America, 2010